substance p has been researched along with Nausea in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| An, HJ; Cho, SS; Kim, HH; Ko, YH; Park, HS; Shim, BY; Sun, S; Won, HS | 1 |
| Fabi, A; Malaguti, P | 1 |
| Egashira, N; Kawashiri, T; Oishi, R; Yano, T | 1 |
| Asano, K; Ito, Y; Kim, S; Ogura, Y; Tasaka, A; Yamamoto, K; Yamatodani, A | 1 |
| Boland, JW; Kyeremateng, S | 1 |
| Beumer, JH; Dienel, S; Eiseman, JL; Horn, CC; Meyers, K; Rigatti, LH; Strychor, S | 1 |
| Molasiotis, A; Raftopoulos, H; Rapoport, BL; Roila, F | 1 |
| Bosnjak, SM; Dimitrijevic, J; Djordjevic, F | 1 |
| Grunberg, S; Hawkins, R | 1 |
| Bonneterre, J; Mailliez, A | 1 |
| Higa, GM; Trigg, ME | 1 |
| Endo, M; Murakami, H; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Batra, U; Chen, C; Hettrick, L; Higgins, R; Kwei, G; Landis, E; Loper, A; Lynn, K; Novak, L; Shelukar, S; Storey, D; Thompson, K; Wu, Y | 1 |
| Hesketh, PJ | 2 |
| Prommer, E | 1 |
| Altaha, R; Auber, ML; Higa, GM; Hobbs, G; Kurian, S; Landreth, K; Piktel, D | 1 |
| Horiba, K; Ishikawa, N; Kanazawa, Y; Koizumi, M; Kudoh, H; Ohkawa, K; Seya, T; Shirakawa, T; Tajiri, T; Tanaka, N; Yamada, T; Yokoi, K; Yoshioka, M | 1 |
| Hartvig, P | 1 |
| Nieber, K; Schoppmeyer, K | 1 |
| Abadías, M; Arañó, P; Conejero, J; Martínez-García, R; Perales, L; Ruíz, JL; Sust, M | 1 |
| Herrstedt, J | 1 |
| Endo, T; Hirafuji, M; Minami, M | 1 |
| Saphir, A | 1 |
| O'Sullivan, GC; Shanahan, F | 1 |
| Feldman, M; O'Dorisio, TM; Samson, WK | 1 |
11 review(s) available for substance p and Nausea
| Article | Year |
|---|---|
An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.
Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Isoquinolines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Radiotherapy; Serotonin 5-HT3 Receptor Antagonists; Substance P; Treatment Outcome; Vomiting | 2013 |
Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Olanzapine; Substance P; Vomiting | 2016 |
Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Neoplasms; Substance P; Treatment Outcome; Vomiting | 2009 |
[Chemotherapy induced emesis: pathophysiology and prevention].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Dopamine Antagonists; Humans; Nausea; Receptors, Tachykinin; Serotonin; Serotonin Antagonists; Substance P; Vomiting | 2010 |
Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
Topics: Animals; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Nausea; Neurokinin-1 Receptor Antagonists; Practice Guidelines as Topic; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Vomiting | 2010 |
Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
Topics: Antiemetics; Drug-Related Side Effects and Adverse Reactions; Humans; Models, Biological; Nausea; Neurokinin-1 Receptor Antagonists; Serotonin; Serotonin Receptor Agonists; Substance P; Vomiting | 2004 |
Aprepitant (EMEND): the role of substance P in nausea and vomiting.
Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Liver; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P; Vomiting | 2005 |
[Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Substance P; Vomiting | 2007 |
New perspectives in antiemetic treatment.
Topics: Antiemetics; Antineoplastic Agents; Humans; Nausea; Serotonin; Serotonin Antagonists; Substance P; Vomiting | 1996 |
[Role of serotonin in emesis].
Topics: Afferent Pathways; Animals; Brain Stem; Cisplatin; Humans; Intestinal Mucosa; Mice; Nausea; Rats; Receptors, Opioid; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Vagus Nerve; Vomiting | 1996 |
Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Nausea; Receptors, Neurokinin-1; Substance P; Vomiting | 2001 |
3 trial(s) available for substance p and Nausea
| Article | Year |
|---|---|
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Immunoenzyme Techniques; Japan; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Morpholines; Nausea; Small Cell Lung Carcinoma; Substance P; Vomiting; Young Adult | 2011 |
5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Biomarkers; Chromatography, High Pressure Liquid; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Immunoassay; Male; Middle Aged; Nausea; Prospective Studies; Substance P; Time Factors; Vomiting | 2006 |
Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Nausea; Pilot Projects; Pyrazoles; Substance P; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics; Vision Disorders; Vomiting; Young Adult | 2009 |
12 other study(ies) available for substance p and Nausea
| Article | Year |
|---|---|
Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy-induced nausea and vomiting: A prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug-Related Side Effects and Adverse Reactions; Emetics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Prognosis; Prospective Studies; Substance P; Survival Rate; Vomiting | 2021 |
[Substance P in antitumor drug-induced adverse reactions].
Topics: Animals; Antineoplastic Agents; Carboplatin; Histamine Antagonists; Humans; Nausea; Neuropeptides; Paclitaxel; Pyridines; Pyrimidinones; Substance P; Vomiting | 2013 |
Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats.
Topics: Animals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Eating; Granisetron; Kaolin; Male; Medulla Oblongata; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Pica; Protein Precursors; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; RNA, Messenger; Serotonin Antagonists; Solitary Nucleus; Substance P; Tachykinins | 2014 |
Aprepitant for the management of refractory emesis in a patient with a small bowel carcinoid tumor.
Topics: Aged, 80 and over; Antiemetics; Aprepitant; Carcinoid Tumor; Female; Humans; Intestinal Neoplasms; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Substance P; Treatment Outcome; Vomiting | 2014 |
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Chemical and Drug Induced Liver Injury; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Emetics; Female; Half-Life; Injections, Intraperitoneal; Kidney; Lung; Nausea; Neurons; Platinum; Shrews; Spinal Cord; Substance P; Tissue Distribution | 2015 |
Chemotherapy-Induced Nausea and Vomiting.
Topics: Drug Therapy; Humans; Nausea; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting | 2015 |
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Topics: Absorption; Administration, Oral; Animals; Antineoplastic Agents; Aprepitant; Area Under Curve; Biological Availability; Capsules; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dogs; Drug Administration Schedule; Drug Evaluation, Preclinical; Fasting; Food-Drug Interactions; Humans; Male; Models, Animal; Morpholines; Nanostructures; Nausea; Substance P; Tablets; Technology, Pharmaceutical; Upper Gastrointestinal Tract; Vomiting | 2004 |
[Substance P and anticancer drug-induced emesis].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Digestive System Neoplasms; Female; Humans; Male; Middle Aged; Nausea; Receptors, Neurokinin-1; Serotonin 5-HT3 Receptor Antagonists; Substance P; Vomiting, Anticipatory | 2007 |
Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Humans; Hydroxyindoleacetic Acid; Nausea; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Time Factors; Vomiting; Vomiting, Anticipatory | 2007 |
Fighting nausea in the '90s: more and better anti-emetics can help.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting | 1997 |
Neurokinin antagonism and chemotherapy-induced emesis.
Topics: Acetals; Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Male; Morpholines; Multicenter Studies as Topic; Nausea; Neurokinin-1 Receptor Antagonists; Randomized Controlled Trials as Topic; Substance P; Vomiting | 1999 |
Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide.
Topics: Adult; Apomorphine; Female; Humans; Infusions, Intravenous; Nausea; Oxytocin; Pancreatic Polypeptide; Substance P; Vasoactive Intestinal Peptide; Vasopressins | 1988 |